Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
Inspire Medical Systems Inc (NYSE: INSP) closed the day trading at $96.54 up 1.33% from the previous closing price of $95.27. In other words, the price has increased by $1.33 from its previous closing price. On the day, 2.75 million shares were traded. INSP stock price reached its highest trading level at $97.76 during the session, while it also had its lowest trading level at $91.15.
Ratios:
For a better understanding of INSP, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.70 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 28.39. For the most recent quarter (mrq), Quick Ratio is recorded 4.01 and its Current Ratio is at 5.29. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
On December 02, 2025, Morgan Stanley Downgraded its rating to Equal-Weight which previously was Overweight but kept the price unchanged to $130. Truist Upgraded its Hold to Buy on November 26, 2025, while the target price for the stock was maintained at $165.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 02 ’25 when mcCormick Shawn sold 1,200 shares for $139.00 per share. The transaction valued at 166,800 led to the insider holds 24,846 shares of the business.
SHAWN T MCCORMICK bought 1,200 shares of INSP for $151,608 on Dec 02 ’25. On Nov 28 ’25, another insider, mcCormick Shawn, who serves as the Director of the company, sold 2,000 shares for $127.48 each. As a result, the insider received 254,960 and left with 26,046 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INSP now has a Market Capitalization of 2855104512 and an Enterprise Value of 2515092224. As of this moment, Inspire’s Price-to-Earnings (P/E) ratio for their current fiscal year is 66.21, and their Forward P/E ratio for the next fiscal year is 56.09. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.39. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.18 while its Price-to-Book (P/B) ratio in mrq is 4.21. Its current Enterprise Value per Revenue stands at 2.85 whereas that against EBITDA is 50.975.
Stock Price History:
The Beta on a monthly basis for INSP is 0.75, which has changed by -0.48533958 over the last 52 weeks, in comparison to a change of 0.14402747 over the same period for the S&P500. Over the past 52 weeks, INSP has reached a high of $216.01, while it has fallen to a 52-week low of $70.77. The 50-Day Moving Average of the stock is -2.01%, while the 200-Day Moving Average is calculated to be -18.69%.
Shares Statistics:
Over the past 3-months, INSP traded about 1.50M shares per day on average, while over the past 10 days, INSP traded about 2737160 shares per day. A total of 29.05M shares are outstanding, with a floating share count of 27.75M. Insiders hold about 4.49% of the company’s shares, while institutions hold 104.46% stake in the company. Shares short for INSP as of 1764288000 were 3481719 with a Short Ratio of 2.32, compared to 1761868800 on 3305009. Therefore, it implies a Short% of Shares Outstanding of 3481719 and a Short% of Float of 16.189999999999998.
Earnings Estimates
A detailed examination of Inspire Medical Systems Inc (INSP) is currently in progress, with 12.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is $0.12, with high estimates of $0.31 and low estimates of -$0.22.
Analysts are recommending an EPS of between $1.65 and $0.99 for the fiscal current year, implying an average EPS of $1.55. EPS for the following year is $1.66, with 12.0 analysts recommending between $2.01 and $1.31.
Revenue Estimates
15 analysts predict $262.3M in revenue for. The current quarter. It ranges from a high estimate of $263.1M to a low estimate of $260M. As of. The current estimate, Inspire Medical Systems Inc’s year-ago sales were $239.72MFor the next quarter, 15 analysts are estimating revenue of $213.38M. There is a high estimate of $223.4M for the next quarter, whereas the lowest estimate is $204.21M.
A total of 17 analysts have provided revenue estimates for INSP’s current fiscal year. The highest revenue estimate was $908.29M, while the lowest revenue estimate was $900M, resulting in an average revenue estimate of $905.03M. In the same quarter a year ago, actual revenue was $802.8MBased on 17 analysts’ estimates, the company’s revenue will be $1B in the next fiscal year. The high estimate is $1.06B and the low estimate is $997.8M.
